1 December 2023
- 21:1421:14, 1 December 2023 diff hist +77 Novel Therapies and Diagnostic Methods (Turku University Hospital Cancer Centre) No edit summary
- 21:1321:13, 1 December 2023 diff hist +78 Trainings: Medical Specialist Trainings (Turku University Hospital Cancer Centre) No edit summary
- 21:1321:13, 1 December 2023 diff hist +78 Courses: Postgraduate Study Courses (Turku University Hospital Cancer Centre) No edit summary
- 21:1321:13, 1 December 2023 diff hist +78 Experts (Turku University Hospital Cancer Centre) No edit summary
- 21:1221:12, 1 December 2023 diff hist +25 Turku University Hospital Cancer Centre →Trials (Turku University Hospital Cancer Centre)
- 21:1121:11, 1 December 2023 diff hist +41,269 N Trials (Turku University Hospital Cancer Centre) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Turku University Hospital Cancer Centre page '''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in part..."
- 21:1121:11, 1 December 2023 diff hist −88 Turku University Hospital Cancer Centre →Trials
- 21:0421:04, 1 December 2023 diff hist +25 Institut Jules Bordet →Trials (Institut Jules Bordet)
- 21:0321:03, 1 December 2023 diff hist +77,439 N Trials (Institut Jules Bordet) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Jules Bordet page '''NCTID''': NCT04966715 '''Title''': Inferior Epigastric Lymph Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Colorectal Peritoneal Metastases '''Study Summary''': In this study, the investigators propose to systematically collect and analyse epigastric lymph nodes during complete cytureductive surgery in patients with colorectal carcinomatosis, in order to d..."
- 21:0221:02, 1 December 2023 diff hist −88 Institut Jules Bordet →Trials
- 21:0121:01, 1 December 2023 diff hist +6,499 Trials (Kortrijk Cancer Centre AZ Groeninge) No edit summary
- 21:0021:00, 1 December 2023 diff hist −131 Kortrijk Cancer Centre AZ Groeninge →Trials
- 20:5620:56, 1 December 2023 diff hist +25 Masaryk Memorial Cancer Institute →Trials (Masaryk Memorial Cancer Institute)
- 20:5520:55, 1 December 2023 diff hist +7,592 N Trials (Masaryk Memorial Cancer Institute) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Masaryk Memorial Cancer Institute page '''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is n..."
- 20:5420:54, 1 December 2023 diff hist −88 Masaryk Memorial Cancer Institute →Trials
- 20:5320:53, 1 December 2023 diff hist +25 Motol University Hospital →Trials (Motol University Hospital)
- 20:5220:52, 1 December 2023 diff hist +10,855 N Trials (Motol University Hospital) Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Motol University Hospital page '''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematop..."
- 20:5220:52, 1 December 2023 diff hist −88 Motol University Hospital →Trials
- 20:5120:51, 1 December 2023 diff hist +25 Vejle Cancer Centre - The Patients' Cancer Hospital part of Lillebaelt Hospital →Trials (Vejle Cancer Centre - The Patients’ Cancer Hospital part of Lillebaelt Hospital)
- 20:5020:50, 1 December 2023 diff hist +4,465 N Trials (Vejle Cancer Centre - The Patients' Cancer Hospital part of Lillebaelt Hospital) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Vejle Cancer Centre – The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered..."
- 20:5020:50, 1 December 2023 diff hist +22 Vejle Cancer Centre - The Patients' Cancer Hospital part of Lillebaelt Hospital →Trials (The Patients’ Cancer Hospital part of Lillebaelt Hospital)
- 20:4820:48, 1 December 2023 diff hist −112 Vejle Cancer Centre - The Patients' Cancer Hospital part of Lillebaelt Hospital →Trials
- 20:4720:47, 1 December 2023 diff hist +25 Tartu University Hospital →Trials (Tartu University Hospital)
- 20:4720:47, 1 December 2023 diff hist +62,771 N Trials (Tartu University Hospital) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Tartu University Hospital page '''NCTID''': NCT04241185 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) '''Study Summary''': This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT a..."
- 20:4620:46, 1 December 2023 diff hist −88 Tartu University Hospital →Trials
- 20:4520:45, 1 December 2023 diff hist +25 North Estonia Medical Centre →Trials (North Estonia Medical Centre)
- 20:4520:45, 1 December 2023 diff hist +53,706 N Trials (North Estonia Medical Centre) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to North Estonia Medical Centre '''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal aden..."
- 20:4220:42, 1 December 2023 diff hist −7 North Estonia Medical Centre →Trials (North Estonia Medical Centre Trials)
- 20:4120:41, 1 December 2023 diff hist +6 North Estonia Medical Centre No edit summary
- 20:4120:41, 1 December 2023 diff hist −116 North Estonia Medical Centre →Trials
- 20:3920:39, 1 December 2023 diff hist +25 East Tallinn Central Hospital →Trials (East Tallinn Central Hospital)
- 20:3920:39, 1 December 2023 diff hist +28,183 N Trials (East Tallinn Central Hospital) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t..."
- 20:3820:38, 1 December 2023 diff hist −7 East Tallinn Central Hospital →Trials (East Tallinn Central Hospital Trials)
- 20:3720:37, 1 December 2023 diff hist −81 East Tallinn Central Hospital →Trials
- 20:2120:21, 1 December 2023 diff hist +94 Service: OLKA (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:2020:20, 1 December 2023 diff hist +94 Service: Support during cancer treatment (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:2020:20, 1 December 2023 diff hist +94 Resource: Trials List (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:1820:18, 1 December 2023 diff hist +94 Novel Therapies and Diagnostic Methods (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:1720:17, 1 December 2023 diff hist +95 Training: Practical training in medicine (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:1620:16, 1 December 2023 diff hist +95 Experts (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:0720:07, 1 December 2023 diff hist +25 Helsinki University Hospital Comprehensive Cancer Center →Trials (Helsinki University Hospital Comprehensive Cancer Center)
- 20:0720:07, 1 December 2023 diff hist +130 Trials (Helsinki University Hospital Comprehensive Cancer Center) No edit summary
- 20:0520:05, 1 December 2023 diff hist +22,801 N Trials (Helsinki University Hospital Comprehensive Cancer Center) Created page with "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: * is advanced or metastatic (spread to other parts of the body); * has a certain type of abnormal..."
- 20:0520:05, 1 December 2023 diff hist +59 Helsinki University Hospital Comprehensive Cancer Center →Trials
- 20:0320:03, 1 December 2023 diff hist −147 Helsinki University Hospital Comprehensive Cancer Center →Trials
- 20:0120:01, 1 December 2023 diff hist +90 Helsinki University Hospital Comprehensive Cancer Center Undo revision 12613 by Francine (talk) Tag: Undo
- 20:0120:01, 1 December 2023 diff hist −90 Helsinki University Hospital Comprehensive Cancer Center →Trials
- 19:5919:59, 1 December 2023 diff hist −19 Helsinki University Hospital Comprehensive Cancer Center Undo revision 12609 by Francine (talk) Tag: Undo
- 19:5919:59, 1 December 2023 diff hist +7 Helsinki University Hospital Comprehensive Cancer Center Undo revision 12610 by Francine (talk) Tag: Undo
- 19:5819:58, 1 December 2023 diff hist −7 Helsinki University Hospital Comprehensive Cancer Center →Trials
